Table 5. Analytes and sample type with significant infection effect where age-effects were also observed in Nigerian children.
Analyte | Sample | Test | P-Value | Age-Group Pairwise | Difference of MeanF or MediansK-W | P-Value |
---|---|---|---|---|---|---|
TFF2 | Serum | F | 0.0479 | 6–8 vs 9–11 | 138.07 | 0.0391 |
TFF3 | Serum | F | 0.0028 | 6–8 vs 12–14 | 150.27 | 0.0029 |
9–11 vs 12–14 | 155.39 | 0.0254 | ||||
IL-10 | Serum | Kruskal-Wallis | 0.0129 | 6–8 vs 12–14 | -59.75 | 0.0021 |
IL-10* | Urine | Kruskal-Wallis | 0.0103 | 6–8 vs 12–14 | -10.87 | 0.0026 |
IL-1β | Urine | Kruskal-Wallis | 0.0082 | 6–8 vs 12–14 | -33.32 | 0.0139 |
9–11 vs 12–14 | -38.97 | 0.0078 | ||||
IL-13 | Urine | Kruskal-Wallis | 0.0121 | 9–11 vs 12–14 | -10.87 | 0.0028 |
*For non-zero data only.